Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)-Reference-Cited by-同舟云学术

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Published:2018-10-26 Issue:1 Volume:49 Page:37-41
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Matsuzuka Takashi¹,Kiyota Naomi²³,Mizusawa Junki⁴,Akimoto Tetsuo⁵,Fujii Masato⁶,Hasegawa Yasuhisa⁷⁸,Iwae Shigemichi⁹,Monden Nobuya¹⁰,Matsuura Kazuto¹¹,Onozawa Yusuke¹²,Hayashi Ryuichi¹³,Tahara Makoto¹⁴^ORCID,

Affiliation:

1. Department of Otolaryngology, Fukushima Medical University Hospital, Fukushima, Japan

2. Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan

3. Kobe University Hospital Cancer Center, Kobe, Japan

4. Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan

5. Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan

6. Department of Otolaryngology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan

7. Asahi University Hospital, Department of Head and Neck Surgery and Otolaryngology, Gifu, Japan

8. Department of Head and Neck Surgery, Aichi Cancer Center, Nagoya, Japan

9. Department of Head and Neck Surgery, Hyogo Cancer Center, Akashi, Japan

10. Department of Head and Neck Surgery, Shikoku Cancer Center, Matsuyama, Japan

11. Division of Head and Neck Surgery, Miyagi Cancer Center, Natori, Japan

12. Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan

13. Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan

14. Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Funder

National Cancer Center Research and Development Fund

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/49/1/37/27565461/hyy145.pdf

Reference21 articles.

1. Cachexia: a new definition;Evans;Clin Nutr,2008

2. Cytokines and cachexia;Matthys;Nutrition,1997

3. Function of C-reactive protein;Du Clos;Ann Med,2000

4. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma;Miki;Dig Dis Sci,2004

5. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer;Forrest;Br J Cancer,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma;World Journal of Surgical Oncology;2024-09-11

2. The Prognostic Value of Serum Albumin to Globulin Ratio in Patients with Breast Cancer: A Retrospective Study;Breast Cancer: Targets and Therapy;2024-07

3. Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan;International Journal of Clinical Oncology;2024-02-14

4. Cachexia and head and neck squamous cell carcinoma: A scoping review;Oral Diseases;2023-10-27

5. Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia;Journal of Cachexia, Sarcopenia and Muscle;2023-09-05